Before you sell to, join or invest in OraLiva, Inc.
MentionFox check on OraLiva, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/oraliva-inc-form-d-25000001
Check OraLiva, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about OraLiva, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
OraLiva, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-21.
OraLiva, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 21, 2025. The filing reports $1.50M sold. Its industry group is Biotechnology. It names Anna Grassini (Executive Officer, Director), John McDevitt (Director) (SEC Form D, March 21, 2025).
Is this your company?
Sell to companies like OraLiva, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns OraLiva, Inc.
Free to see. No signup.
More on the people and the money behind OraLiva, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when OraLiva, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when OraLiva, Inc. raises, hires or launches. No email unless you switch it on.
Watch OraLiva, Inc. →Get the full cited report on OraLiva, Inc.
What the filing shows about OraLiva, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on OraLiva, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives OraLiva, Inc.'s address as 2 Davis Drive, Durham, NC 27709.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
OraLiva, Inc. is a registered filer with the SEC (CIK 1963569) and has filed since 2025-03-21. 1 filing is on record, the latest on 2025-03-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
OraLiva, Inc.'s Form D of 2025-03-21 names Anna Grassini and John McDevitt as its officers, directors or promoters.
Its new offerings report $1.50M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Proceeds will be used for working capital, which may include normal compensation to executive officers.
Anna Grassini is named as Executive Officer and Director on the Form D that OraLiva, Inc. filed with the SEC on 21 March 2025, one of 2 people that filing names.
John McDevitt is named as Director on the Form D that OraLiva, Inc. filed with the SEC on 21 March 2025, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2025-03-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about OraLiva, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on OraLiva, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OraLiva, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist OraLiva, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind OraLiva, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for OraLiva, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/oraliva-inc-form-d-25000001